T-250

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameT-250
Drug Alias NameT-250
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsPeripheral Vascular DiseasesAngina, Unstable
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesToyama Chemical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesToyama Chemical Co Ltd
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular DiseasesAngina, Unstable

Other Information

ATC CodeN/A
Related LinksN/A